Tedco awards $600K to tech firms - Denver Business Journal:

eragywaqer.wordpress.com
The money was granted in collaboration withthe U.S. Army Medicall Research and Materiel Command and the througthe Ft. Detrick Technology Transfef Initiative. The purpose of the technology transfet program is to raise awarenesas of new and developing technologie s and funding them to transition as viable projectdfor follow-on funding in the market place. Each companhy that received funding was awardedapproximately $50,000 between Marcjh 2008 and May making up the initiative’s second round of financialp awards since its $750,000 program extension. The fundsz for the program’s second phase were secured by Sen. Barbarza Mikulski, D-Md., and Rep. Roscoe G. R-Md. “The [Ft.
Detrick Technology Transfer Initiative] progra is enabling area businesses to harneses the technologies being developed at Fort Detric k and apply them to thecommercial sector,” said “This will lead to new products that have the powere to create jobs and save Mikulski announced the first phase of the tech transfer prograj in March 2005 when 11 companies received funding. in The company is developing a health care technology calle dmiTag system, which is a scalablde wireless sensor solution for improving patient in Frederick: The company is developing a technology called the GeNovaq Screen to identify, isolate, and producs antibody-like molecules.
in Rockville: The company is developing an on-demanc biotech products including a combination vaccine againstf plagueand anthrax. BioAssay Works LLC in The company is developinga lateral-flow visual diagnostic test to detecg and differentiate single sample multiple pathogenic including variola, vaccinia, and monkeypox. in The company is safety-testing a medical product called ClotFoam, which is a intracavitary hemostatic agent. CynerGene IDMP in The companyis developing, validating and implementingy a supplemental diagnosis of Malaria, HIV, and Dengue usingf its Infectious Disease Multiplex Panel approach, whicj could allow for creation of biosensors.
LLC in Baltimore: The companyu is developing required components and syste m framework to enable conversational interfaces fortelemediciner tools. Such tools would allo w professional medics touse voice, and other human-- computer interactionzs to access and document information in electronic medica records. in Rockville: The company is developing technology to preserv e mammalian cells in dried format that can easilybe re-hydratede for a variety of uses. LLC in The company is evaluating the effect of Imagili patented probiotics as a food supplemengt to enhance the immune responsiveness of guinesa pigs upon immunization or challenge withvirulent pathogens.
The evaluationn will suggest the ability of Imagilij patented probiotics to enhance the immunizatioh ofa vaccine. in The company is developing micropatterned substrates for viralinfectivityu assays. Juxtopia in Baltimore: The company is customizing its Wearabled Assistance and SituationalAwareness (WASA) goggles and servicew to allow U.S. Army combat medice to access and document information to electrical medical recordsvia hands-free voice-requests and voice-responses. in The company is developing cell therapies to trear brain and spinalcord injuries.